Regulatory T Cells and Viral Disease by Tanya LeRoith & S. Ansar Ahmed
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
6 
Regulatory T Cells and Viral Disease 
Tanya LeRoith and S. Ansar Ahmed 
Virginia Tech 
USA 
1. Introduction 
The mammalian immune system has the ability to distinguish self from non-self-antigens, a 
phenomenon which begins in the thymus during T cell development. T cells that express a 
fully rearranged T cell receptor (TCR) with a high affinity for self-antigens presented in the 
thymus are deleted or undergo anergy in a process known as negative selection. Because of 
this mechanism, T cells in the periphery are primarily specific for non-self-antigens. 
However, this process is somewhat inefficient, because some self-reactive cells escape 
deletion therefore additional mechanisms are required to maintain peripheral immune 
tolerance. Regulatory T cells (Tregs) are a distinct subset of T cells that are critical for 
maintaining both immune homeostasis and peripheral immune tolerance. Tregs are typically 
identified by expression of the forkhead box 3 (FoxP3) transcription factor. The majority of 
FoxP3+ cells also express CD4 and express high levels of the IL-2 receptor (CD25). 
Additional subsets of Tregs that have been described in humans and mice include Tr1 cells, T 
helper 3 cells (Th3), NK cells, and CD8+ Tregs (Beissert S, 2006). CD4+ T cells that express 
high levels the IL-2 receptor (CD25high) do not respond to T cell receptor (TCR) activation 
or mitogen stimulation, and inhibit IL-2 transcription in CD25- cells. Suppression of CD25- 
cells is contact dependent, and requires activation of the Tregs through the TCR; however, 
once activated, the suppressor effector function is nonspecific (Thornton AM, 2000). In mice 
and humans, FoxP3+ cells also express high levels of cytotoxic T lymphocyte-associated 
antigen 4 (CTLA-4) and glucocorticoid-induced tumor necrosis factor receptor (GITR) on the 
surface (Bacchetta R, 2005). CD4+CD25+ T cells suppress the immune response to some 
viruses, protozoa, and bacteria, and aid in the survival of intracellular pathogens 
(Sakaguchi, 2003) most likely by potent suppression of proliferation and IFN- production of 
both CD4+ and CD8+ T lymphocytes (Bacchetta R, 2005). Tr1 cells secrete high amounts of 
IL-10 and moderate amounts of TGF-. Inhibiting IL-10 with neutralizing antibody blocks 
the suppressor effects of Tr1 cells (Beissert S, 2006). Th3 cells produce high concentrations of 
TGF- and moderate amounts of IL-10, and the suppressor effects are not antigen specific 
(Beissert S, 2006). Interestingly, Th3 cells suppress the activation of both Th1 and Th2 cell 
clones while other subsets primarily inhibit Th1 cells and have no effect on Th2 cells 
(Beissert S, 2006). A number of studies have shown that Tregs affect the magnitude of 
immunity and outcome of viral infections, especially with persistent viruses that give rise to 
chronic lesions (Rouse BT, 2006). Depletion of Tregs prior to infection using a monoclonal 
antibody against the IL-2 receptor results in enhanced in vivo CD8+ and CD4+ T 
lymphocyte proliferation, and increased mucosal antibody levels in response to herpes 
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simplex viral infection in mice (Rouse BT, 2006). Humans with chronic hepatitis C virus 
have IL-10-producing Tr1 cells, while those who control infection do not. The IL-10 - 
producing cells were shown to modulate the activity of protective IFN- producing T 
lymphocytes, and both the Th1 and regulatory T cells were induced against the same 
epitopes (MacDonald AJ, 2002). Additionally, immunosuppression induced by chronic 
retroviral infection in the absence of T cell depletion was shown to be mediated by CD4+ 
regulatory T lymphocytes in mice (Iwashiro M, 2001). Importantly, these regulatory T 
lymphocytes suppressed IFN- production by CD8+ T lymphocytes, contributing to virus 
persistence (Dittmer U, 2004). The ability of viruses to induce proliferation and activation of 
regulatory T cells likely contributes to delayed clearance and persistence in the host. 
2. Regulatory T cell biology and development 
Following infection, naïve CD4+ T cells recognize antigen presented on antigen presenting 
cells, bound to class II major histocompatibility complexes (MHC class II). These CD4+ T 
cells expand and differentiate into effector T cells that can become polarized into distinct 
subsets depending on the cytokine environment (McKinstry KK, 2010). The best 
characterized are Th1 and Th2 subsets that have been associated with cell-mediated (Th1) 
and humoral (Th2) immunity (reviewed in (Sakaguchi S, 2010). In addition to T cells, B cells, 
and plasma cells are vital in development of humoral immunity. The role of plasma cells in 
antibody development is beyond the scope of this discussion. Recently, additional subsets 
have been described, including Th9, Th17, Th22, T-follicular helper cells (Tfh), and 
regulatory T cells. Recent studies have shown that multiple CD4+ T cells are actually 
generated in vivo, rather than distinct subsets as previously thought. The effector cells 
secrete large amounts of cytokines, chemokines, and other proteins that can produce 
cytotoxicity to host tissues, or induce autoimmunity. Until recently, control of Treg function 
was believed to have primarily been through cytokine signaling. However, there is evidence 
that Tregs can also sense pathogens through toll-like receptors (TLRs) which modifies their 
behavior (Sutmuller RPM, 2006). The role of cytokines and TLRs in controlling Treg function 
will be discussed separately. 
 
Th subset Selected Key Transcription factors Cytokines produced 
Th1 T-bet IFN-Ǆ, TNF, IL-2 
Th2 GATA-3 IL-4, IL-5, IL-13 
Th17 ROR-Ǆt IL-17, IL-22 
Tfh Bcl-6 IL-4, IL-21 
Treg Foxp3 IL-10 
Table 1. CD4+ T cell subsets (modified from (McKinstry KK, 2010)) 
Regulatory T cells function to provide a balance between combating pathogens and the risk 
of developing autoimmunity or overwhelming inflammation. Regulatory T cells can be 
divided into two groups – natural Tregs develop in the thymus, while inducible Tregs are 
generated in the periphery from conventional T cells in response to different stimuli. The 
natural Tregs are the best characterized of the two groups and make up approximately 5-10% 
of circulating T lymphocytes in mice and humans (Gückel E, 2011). Regulatory T cells are 
primarily characterized by the expression of the transcription factor FoxP3. FoxP3 maintains 
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Treg gene expression induced by other transcription factors rather than actually driving Treg 
development. However, FoxP3 is essential for Treg function since loss of FoxP3 function 
results in severe lymphoproliferative disease and autoimmunity in humans and mice 
(Bennett CL, 2001). The role of FoxP3 in maintaining self-tolerance was first identified in 
scurfy mice, and then in humans with immunodysregulation, polyendocrinopathy, 
enteropathy, X-linked (IPEX) syndrome, both of which have a FoxP3 mutation as the 
underlying genetic defect. Humans express two isoforms of FoxP3 (A and B), either of 
which has regulatory function. FoxP3B contains a deletion of the proline-rich exon 2 which 
is required to bind to the retinoic acid receptor-related orphan receptor-ǂ (RORǂ). In 
addition, FoxP3B  lacks the amino-terminal residues that interact with nuclear factor of 
activated T cells (NFAT) (Sakaguchi S, 2010). In humans, FoxP3 expression on Tregs is 
transient, and downregulation of FoxP3 expression decreases the ability of these cells to 
suppress. In contrast, this transient expression has not been found in mice; however, mouse 
conventional T cells can be converted to FoxP3+ T regs following stimulation with TFGǃ or 
retinoic acid. These adaptive Treg cells also express FoxP3, CD25, and CTLA4 (Sakaguchi S, 
2010). In humans, FoxP3+ T cells stimulated with TGFǃ do not have suppressive activity 
and may require other factors to develop Treg function. Both natural and induced Treg cells 
have unique surface markers that differentiate them from conventional T cells. The surface 
marker expression is summarized in Figure 1. 
2.1 Natural regulatory T cells 
Natural regulatory T cells were first discovered in two animal models of autoimmunity. In 
the first, neonatal mice were thymectomized at 2-4 days of life. These mice developed 
autoimmune disease that could be abrogated by adoptive transfer of CD4+ T cells from 
normal mice. In the second, adult rats were thymectomized and subjected to X-ray 
irradiation. Adoptive transfer of CD4+ T cells from normal rats similarly abrogated the 
autoimmune disease, suggesting that CD4+ T cells within the thymus suppressed the 
development of autoimmunity. Later experiments showed that adoptive transfer of 
thymocytes depleted of CD4+CD25+ cells resulted in the development of autoimmune 
disease in syngeneic T cell deficient mice (reviewed in (Sakaguchi S, 2010)). Thymic stromal 
cells and dendritic cells are critical for nTreg development. Natural regulatory T cells develop 
in the thymus through interactions between the high-affinity T cell receptor and cognate 
antigens on thymic epithelial cells. Co-stimulation through CD28 and common gamma (cǄ) 
chain cytokines, especially IL-2 and IL-7 have also been shown to be necessary for nTreg 
development. Signal transducer and activation of transcription 5 (STAT5) signaling through 
the cǄ chain is also required. Thymic development of nTreg cells follows a two-step process: 
1), thymocytes upregulate CD25 and other IL-2 signaling molecules in response to 
TCR/CD28 co-stimulation and 2), CD4+CD25highFoxP3- Tregs respond to IL-2 independent of 
the TCR, and induce FoxP3 expression in response to STAT5 activation (Gückel E, 2011). Treg 
cell-intrinsic NF-κB activation is essential for thymic Treg development (Gückel E, 2011). 
Naturally occurring Tregs cannot produce IL-2 and therefore rely on paracrine IL-2 
production from conventional T cells. Mice deficient in IL-2 or CD25 have reduced numbers 
of FoxP3+ T cells and a dramatic reduction in peripheral and thymic Tregs. In humans, 
Hassall’s corpuscles in the thymic medulla secrete thymic stroma lymphopoietin (TSLP) 
which activates immature dendritic cells and upregulates the expression of co-stimulatory 
molecules. The activated DCs induce FoxP3 expression in CD4+CD8-CD25- thymocytes 
(Sakaguchi S, 2010). 
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Fig. 1. Regulatory T cell development. The phenotype of different stages of CD4+ T cell 
differentiation into the conventional T cell and regulatory T cells are shown. The T cells 
originate in the thymus and emigrate as naïve CD45RA+ T cells to the periphery where they 
are activation. Activation induces differentiation into either conventional or regulatory T 
cells. Conventional T cells can then differentiate into memory T cells. Treg cells have not yet 
been shown to produce memory cells, but they do differentiate into terminal effector Tregs. 
Treg-like cells are induced from conventional T cells depending on cytokine stimulation. 
These converted Treg-like cells have cell surface markers similar to those expressed by 
natural Tregs. CTLA4, cytotoxic T lymphocyte antigen 4; FOXP3, forkhead box P3 (Modified 
from (Sakaguchi S, 2010)). 
2.2 Inducible regulatory T cells 
A less well-characterized subset of regulatory T cells is the inducible Tregs that develop from 
conventional T cells under certain conditions. iTregs are induced by prolonged exposure to 
circulating antigen or weak co-stimulation in the periphery. Additionally, soluble factors 
such as the cytokines IL-4, IL-10 and TGF-ǃ, retinoic acid or neuropeptides can enhance 
Foxp3 upregulation and iTreg generation in the periphery. FoxP3 expression induces 
upregulation of other Treg molecules including CTLA-4, GITR, and CD127. Tr1 cells secrete 
IL-10, while Th3 cells secrete TGF-ǃ. Other cells with adaptive regulatory function include 
some CD4-CD8- and CD8+CD28- T cells (Sakaguchi S, 2010). Early after iTregs are 
stimulated, they express high levels of cell-cycle progression and T cell activation-associated 
genes (Prots I, 2011), mimicking genes that are upregulated in activated effector T cells. As 
iTregs mature, expression of these genes diminishes while they remain high in mature 
effector T cells. By 10 days after differentiation into iTregs, most cell cycle progression and T 
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cell activation genes are expressed at levels approximately 3 times lower than in effector T 
cells. In addition, genes in the FoxO family of transcription factors are over-expressed in 
iTregs compared to overexpression of the FoxM1 family in effector cells (Prots I, 2011). 
2.3 Toll-like receptors 
At the center of the balance between protective immunity and autoimmunity are the pattern 
recognition receptors on antigen presenting cells that activate innate immunity and provide 
the bridge between innate and adaptive immunity. Pattern recognition receptors include 
Toll-like receptor molecules (TLRs), Nod and Nod-like receptors, RIG-I-like receptors 
(RLRs), and C-type lectin receptors (Dai J., 2009). TLRs are critical for sensing pattern 
associated molecular patterns (PAMPs) such as those from bacteria, viruses, protozoa, and 
fungi, and act to bridge innate and acquired immunity. Stimulation of TLRs by PAMPs 
alerts the immune system to the presence of microbial infections, triggers maturation in 
dendritic cells, and allows them to initiate adaptive immunity. TLRs have recently been 
found to be expressed on Tregs as well, and may act to curtail excessive inflammation, 
autoimmunity, and sepsis (Sutmuller RPM, 2006). However, TLR signaling has also been 
shown to block Treg activity, leading to an enhanced immune response. Therefore, the 
function of Tregs can be attenuated or enhanced depending on TLR activity in response to 
certain pathogens (Dai J., 2009). Of the thirteen TLRs that have been identified in mice and 
humans, Tregs express TLRs 7, 8, and 9 intracellularly, and 1, 2, 4, 5, 6, and 10 on the surface. 
Additionally, Treg subsets express significantly more TLR4, TLR5, TLR7, and TLR8 than 
conventional T cells. TLR4 recognizes lipopolysaccharide (LPS), which is produced by gram 
negative bacteria, while TLR2 is activated by lipoteichoic acid (LTA) and bacterial 
lipoproteins. TLR7 and TLR8 recognize single stranded RNA, and TLR9 recognizes 
unmethylated CpG DNA motifs found primarily in DNA viruses and some prokaryotic 
genomes (Sutmuller RPM, 2006). Interestingly, bacterial product signaling through TLR 2, 4, 
and 5 results in increased Treg function in a MyD88 and phosphatidylinositol 3-kinase (PI-3 
kinase)-dependent fashion; while signaling through intracellular TLRs 7, 8, and 9 decreases 
Treg function (Dai J., 2009). The reason for the dual function of Tregs in infection is unclear; 
however Dai et. al suggest that the dual response is a necessary pathogen-specific response. 
On the one hand, bacterial and fungal products are responsible for acute sepsis, and these 
products are recognized by cell surface TLRs 2, 4, and 5. A robust anti-inflammatory 
response is necessary to prevent overwhelming inflammation in septic individuals. On the 
other hand, viruses do not cause sepsis, and an adaptive immune response is necessary for 
protective immunity. Recognition of viruses through intracellular TLRs 7, 8, and 9 ensures a 
robust effector T cell response by inhibiting the function of Tregs (Dai J., 2009). Alternatively, 
changes in Treg function may be a result of the expression levels, the density, or the 
subcellular localization of TLRs, or of differential expression of co-stimulatory or accessory 
molecules, or the cytokine milieu. Importantly, TLR2 seems to be crucial in expanding and 
regulating Treg function. TLR-2 deficient mice have significantly fewer Treg cells than control 
mice, and administering TLR2 ligands to wild-type mice increases Treg numbers. TLR2 
triggering, IL-2 treatment, and TCR ligation can overcome Treg anergy in vitro and in vivo. 
Additionally, Foxp3 expression was decreased following TLR2 stimulation of Treg cells. How 
TLR-signaling affects Foxp3 expression is still unknown. TLR2 ligand also increases IL-2 
receptor expression on Tregs and induces IL-2 production by conventional T cells resulting in 
IL-2 mediated abrogation of suppression (Sutmuller RPM, 2006).  
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2.4 Cytokines 
Recently, the Th1/Th2 paradigm has shifted to focus on other subsets of T cells. The focus 
has been on the relationship between regulatory T cells and CD4+ T cells that secrete IL-17 
(Th17 cells). These cells are derived from a common progenitor cell, and develop in response 
to the cytokine milieu. Tregs and Th17 cells even share common chemokine receptors and 
homing properties (Kanwar B, 2010). The balance between these subsets is important in 
many immune disorders related to host-pathogen interaction, inflammatory syndromes, 
autoimmune disease, and immunodeficiency. Treg cell development is dependent on 
cytokine production: the presence of TGF-ǃ favors Treg differentiation (Fig 2), while the 
addition of IL-6 favors Th17 development, and IL-4 and TGF-ǃ favors Th9 development 
(Jutel M, 2011). TGF-ǃ upregulates the retinoic acid receptor-related orphan receptor-Ǆt 
(ROR-Ǆt), which is a master transcription factor of Th17 differentiation. TGF-ǃ also induces 
FoxP3 upregulation when IL-6 is not present. The presence of IL-6 inhibits Treg development 
and induces development of Th17 cells. One of the first ways found to modify Treg function 
was using high concentrations of IL-2. Adding extra IL-2 to in vitro suppression assays 
resulted in abrogation of suppression. It was then found that IL-2 can both overcome Treg-
mediated suppression, as well as enhance Treg function by upregulating IL-10, FoxP3, and 
CTLA-4. IL-2 - deficient mice fail to generate functional regulatory T cells in the periphery, 
lose CD4+ T cell homeostasis, and suffer from lethal lymphoid hyperplasia, 
 
 
Fig. 2. The differentiation of naïve T cells into effector T cells is mediated by cytokines in the 
microenviroment. The resulting cytokine profiles, responses to chemokines, and interactions 
with other cells promote different types of inflammatory responses. In the presence of TGFǃ 
alone, naïve T cells differentiate into regulatory T cells. However, if IL-4 or IL-6 is present, 
the naïve T cells differentiation into proinflammatory Th9 or Th17 cells. IFN, interferon; IL, 
interleukin; TGF, transforming growth factor; TNF, tumor necrosis factor (modified from 
(Jutel M, 2011)) 
www.intechopen.com
 
Regulatory T Cells and Viral Disease 
 
127 
underscoring the significance of IL-2 in Treg development (Sutmuller RPM, 2006). Studies 
have shown that IL-2 production by effector T cells is not affected; however, Tregs act as an 
IL-2 sink, and sequester IL-2 from the supernatant. Therefore IL-2 likely plays a dual role in 
boosting Treg function while allowing effector T cells to escape Treg-mediated suppression 
(Walker, 2009). Interestingly, IL-15 can take over many of IL-2’s functions as a growth factor 
in vitro, a phenomenon that may be related to the fact that IL-15 signals through the 
common IL-2 receptor ǃ and Ǆ chains. However, IL-15 deficient mice do not develop 
lymphoid hyperplasia, suggesting that IL-2 is more important in Treg development 
(reviewed in (Sutmuller RPM, 2006)). 
2.5 The suppressive activity of regulatory T cells 
Currently, human Treg-mediated suppression has only been studied in vitro and it is not yet 
clear if in vitro suppression translates to what occurs in vivo. Additionally, the exact 
molecular mechanism of suppression is not yet known. However; the mechanism of 
suppression has been studied both in vivo and in vitro in mice and may provide clues as to 
what occurs in humans. Even though conventional T cells in mice can be induced to express 
high levels of FoxP3 and have suppressive activity (unlike humans), mice nevertheless 
provide a valuable animal model to study the overall mechanism of Treg-mediated immune 
suppression. From mouse studies, we know that several mechanisms may be involved, 
including cytokine expression, metabolic disruption of the target cell, the alteration of the 
ability of dendritic cell to activate conventional T cells, and cytolysis (Sakaguchi S, 2010). For 
example, CTLA4 expressed by Tregs can alter expression of CD80 and CD86 on dendritic 
cells and prevent activation of effector T cells (Wing K, 2008). Treg-mediated suppression 
requires initial activation through the T cell receptor (Thornton AM, 2000). However, once 
activated, they do not require antigen-specific TCR activation. In fact, following TCR 
activation, Tregs typically undergo apoptosis yet remain suppressive. Surprisingly, even 
paraformaldehyde-fixed Tregs retain their suppressive function. Suppression also depends 
on the level of effector T cell activation. Those effector T cells that receive strong co-
stimulatory signals remain refractory to Treg-mediated suppression. Additionally, growth-
promoting cytokines can overcome Treg function. This suggests that inflammatory responses 
cannot be modulated in conditions where strong pro-inflammatory signals predominate 
(Sakaguchi S, 2010). The direct interaction between DCs and Treg can also influence Treg 
function. Treg cells can downregulate co-stimulatory molecules on immature DCs; however, 
mature DCs are resistant to Treg effects. Mature DCs express high levels of CD80, CD86, and 
CD40 which can increase Treg numbers. DCs can also overcome Treg-mediated suppression 
through the tumor necrosis factor receptor superfamily. Glucocorticoid-induced TNF 
receptor family-related gene (GITR), OX40, 4-1BB, and RANK can all block Treg -mediated 
suppression. GITR is expressed at high levels on Tregs, and the ligand is expressed primarily 
on DCs and macrophages. Triggering through GITR induces Treg proliferation but can also 
block suppression (Sutmuller RPM, 2006). 
3. Regulatory T cells in cancer 
Tregs play a dual role in preventing and enhancing disease in cancer. On one hand, Tregs have 
been shown to inhibit the activation of both CD4+ and CD8+ tumor-suppressor T 
lymphocytes, and suppress anti-tumor immunity (Zamarron BF, 2011). A correlation 
between greater numbers of FoxP3+ T cells and larger invasive breast ductal carcinomas 
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was found in sentinel lymph nodes of patients (Gupta R, 2011). Similarly, depletion of 
FoxP3+ T cells enhances tumor rejection in mice (Zamarron BF, 2011). In these examples, 
strategies to prevent Treg activation would be needed to enhance anti-tumor immunity. On 
the other hand, chronic inflammation can promote the development of cancers such as feline 
vaccine associated sarcomas, feline post-traumatic ocular sarcomas, and colon and 
hepatocellular carcinomas in humans. In these cases, activating Tregs may be necessary to 
prevent the progression to cancer. Anti-tumor immunity or immunosurveillance is 
necessary to prevent the development and progression of cancers, through the recognition 
and elimination of tumor cells. Elimination of tumor cells is primarily dependent on Th1 
and CD8+ T cells, and pro-inflammatory cytokines like IFN-Ǆ. It is well established that 
immunosuppression results in an increase in viral-associated neoplasia. CD4+ Tregs initially 
respond to limit chronic inflammation; however, once tumors are established, their 
immunosuppressive effect limits anti-tumor immunity and promotes tumor cell growth. 
Higher numbers of Tregs are associated with a shorter time to treatment in patients with 
chronic lymphocytic leukemia (Weiss L, 2011). Increased expression of FoxP3 and higher 
numbers of FoxP3+ T cells is associated with a poorer prognosis and shorter time to 
recurrence in ovarian cancer (Wolf D, 2005), metastatic melanoma (Knol AC, 2011), and 
gastric cancer (Shen Z, 2010). Paradoxically, in humans, hepatocellular carcinoma is often 
associated with chronic hepatitis B or C infection. The proposed mechanism is that chronic, 
unresolved inflammation triggers tumor growth, angiogenesis, and tumor survival 
(Grivennikov SI, 2010). Additionally, autoimmune diseases are associated with the 
development of lymphoma, and colon cancer is associated with chronic intestinal 
inflammation and ulcerative colitis (Grivennikov SI, 2010). Interestingly, Tregs within the 
tumor microenvironment of most cancers are associated with a poor prognosis; however, 
high Treg infiltration in colon cancer is associated with a favorable prognosis (Ladoire S, 
2011). Importantly, this favorable prognosis is not associated with inactivation or loss of 
function of mismatch repair genes (reviewed in Ladoire, et al, 2011 (Ladoire S, 2011)). While 
TGFǃ is required for activation of FoxP3, the addition of IL-6 results in activation of Th17 
cells through the transcription factor RORC. Th17 cells produce IL-17 in the tumor 
microenvironment. IL-17 has an angiogenic effect, promoting cancer growth and survival, 
which is necessary for tumor progression. In conditions of excessive inflammation, IL-6 and 
TGF-ǃ may inhibit Treg function and promote the development of Th17 cells. A recent study 
by Tosolini et. al demonstrated that colorectal cancers with high numbers of Th17 have a 
significantly worse prognosis than those with high numbers of Treg cells (Tosolini M, 2011). 
Although strategies to block Treg function in the treatment of cancer to enhance tumor 
immunity may be effective for some cancers, they cannot be used as widespread treatments 
because of the dual role of Tregs in the development and progression of cancer. 
4. Viral-mediated regulatory T cell induction  
Regulatory T cells typically increase late in chronic viral disease to prevent a persistent 
inflammatory response and viral-mediated immunopathology. In fact, tissue-protective 
effects of Treg were shown in models of respiratory syncytial virus, Friend virus, and West 
Nile Virus infection. Additionally, Treg responses to viruses (and bacteria) form the basis of 
the “hygiene hypothesis.” Infection with influenza A in suckling mice protected these mice 
as adults against allergy induced airway hyperactivity due to the expansion of allergen-
specific regulatory T cells (Chang YJ, 2011). Additionally, regulatory T cells responses to 
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Mycobacterium spp. may provide the explanation for the decreased incidence of asthma and 
autoimmune diseases in developing countries. However, some viruses have exploited the 
regulatory immune response, and trigger Treg activation early in the course of disease, 
leading to immune suppression and viral persistence. Viruses activate endosomal TLRs 3, 7, 
8, and 9 (Rouse BT, 2010). Of those, only TLR 7, 8, and 9 are expressed in Tregs (Dai J., 2009). 
Rather than triggering pro-inflammatory cytokines like IFN-ǂ or IFN-Ǆ, persistent viruses 
often trigger production of IL-10 and TGF-ǃ. For example, dendritic cells infected with 
Japanese encephalitis virus have increased production of IL-10 and decreased production of 
IFN-ǂ and TNF-ǂ. In addition, when these infected DCs are cultured with allogenic T cells, 
they also expanded the population of regulatory T cells (Cao S, 2011). Dendritic cells from 
lymphocytic choriomeningitis virus-infected mice and monocytes from people infected with 
hepatitis B, hepatitis C, and human immunodeficiency virus similarly produce increased 
levels of IL-10 (reviewed in (Rouse BT, 2010)). IL-10 blocks production of pro-inflammatory 
cytokines and chemokines, and down-regulates MHC class II expression. IL-10 can also 
inhibit pro-inflammatory cytokine signaling pathways such as NF-κB. In addition, IL-10 
suppresses phosphorylation of STAT1 and induces suppressor of cytokine signaling 3 
(SOCS3) expression by neutrophils and macrophages (Rouse BT, 2010). Protective immunity 
against hepatitis C virus is associated with a robust Th1 response and production of IFN-Ǆ. 
However, approximately 85% of patients respond with IL-10-producing CD8+ and CD4+ T 
cells, and occasionally FoxP3+ Tregs (Wang J-P, 2010). These patients develop chronic HCV 
infection, while those that respond with a Th1 response clear the virus (Rouse BT, 2010). 
Hall et al showed that HCV-infected hepatocytes are capable of inducing Tregs. HCV-infected 
hepatoma cell lines were co-cultured with activated CD4+ T cells resulting in decreased 
production of IFN-Ǆ and increased expression of CD25, CTLA-4, FoxP3, and LAP. These 
Tregs were able to suppress effector T cells and upregulate production of TGF-ǃ. Treg function 
and phenotype was inhibited by blocking TGF-ǃ, suggesting that this phenomenon is also 
TGF-ǃ dependent (Hall CHT, 2010). Early in disease, Tregs, TGF-ǃ, and IL-10 production in 
HCV infection are associated with development of chronic infection. On the other hand, in 
patients already chronically infected with HCV, IL-10 production does appear to have a 
protective effect since patients with the highest level of IL-10 tend to have a better prognosis.  
Disease progression in human and simian immunodeficiency virus infection is associated 
with the loss of Th17 cells, and an increase in CD4+FoxP3+ Tregs. Surprisingly, the loss of 
Th17 cells was associated with increased immune activation. Investigators found that 
because Th17 cells were responsible for maintaining the integrity of the mucosal barrier in 
the intestine, loss of Th17 cells resulted in increased microbial translocation across the gut 
(reviewed in (Kanwar B, 2010). Both HIV and SIV infection trigger an increase in regulatory 
T cells that produce TGF-ǃ1. This in turn triggers TGF-ǃ1 signaling in fibroblasts resulting in 
production of chitinase 3-like1 (CHI3L1) and pro-collagen. CHI3L1 enhances maturation of 
the procollagen into collagen in lymphoid tissue fibroblasts resulting in lymphoid tissue 
fibrosis. Lymphoid tissue fibrosis limits access of lymphocytes to reticular cells and IL-7 
which depletes naïve CD4+ T cells. This may be one mechanism of CD4 depletion in HIV 
(Zeng M, 2011).  
Further evidence of the role of Tregs in chronic viral infections is seen in the mouse model of 
infection with lymphocytic choriomeningitis virus (LCMV). Infections with different strains 
of LCMV can either cause acute infection that is cleared within a week (Armstrong strain), 
or chronic infection in which the mice are infected for life (variant clone 13). In variant clone 
13-infected mice, mice with a specific TCR (Vǃ5) have more prominent activation and 
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expansion of Tregs. These Tregs expand from an existing Treg -population and expansion is 
dependent on retrovirus-encoded superantigens in the mouse genome (Punkosdy GA, 
2011). However, it is not known if the Treg expansion is involved in establishing chronic 
infection in this model. These viruses and others have exploited the phenomenon of 
activation of Tregs in response to infection by triggering Treg proliferation early in disease 
progression. Treg activation allows them to evade the host immune response and persist in 
the host. Using animal models to understand the mechanism of Treg activation and 
expansion is vital to developing strategies to combat some of the persistent viral diseases 
that are not controlled well by vaccination. 
5. The pig as an immunological model 
Pigs provide a powerful tool in viral immunology studies, including the study of both 
innate and adaptive immunity. Germ free and gnotobiotic pigs can be relatively easily 
derived by cesarean section, and since pigs have epitheliochorial placentation, there is no 
interference by maternal antibody if the pigs are removed from the dam before suckling 
(Butler JE, 2009),(Butler JE, 2007). Although outbred, the pig is large enough that all in vitro 
tests can be done using cells from the same animal. Additionally, litter sizes are very large, 
decreasing genetic diversity of individual animals. Like humans, each individual can be 
treated as a biological unit (Butler JE, 2009), and using isolator piglets can decrease 
environmental variables. Pigs have digestive and respiratory systems, as well as T cell 
receptor and light chain repertoires that are similar to humans (reviewed in Butler, et al., 
2009(Butler JE, 2009)). Importantly, porcine dendritic cells (DC) resemble human DCs, 
making them ideal to study pathogen responses relevant to humans (Paillot R, 2001; 
Raymond CR, 2005; Summerfield A, 2009). Additionally, porcine regulatory T cells function 
similarly to humans. 
6. Porcine regulatory T cells 
While regulatory T cells had been described and characterized in humans and mice since 
1995 (Sakaguchi S, 1995), they were not demonstrated in pigs until 2008 (Käser T, 2008a, b). 
Although FoxP3 expression has been found in cells without suppressive activity in mice 
(Chen X, 2011), FoxP3 remains the most relevant phenotypic marker for Tregs in pigs. 
Identification and characterization of these cells was made possible by the fact that the anti-
mouse monoclonal antibody FJK-16s (eBiosciences, San Diego, CA) cross-reacts with porcine 
regulatory T cells (Käser T, 2008b). The majority of FoxP3+ cells are also CD25+; however, in 
contrast to the findings of Käser et. al, we identified a small percentage of porcine FoxP3+ 
cells that do not express CD25. Besides CD4+ Tregs, FoxP3 expression was also found on 
CD4-CD8ǂ+ T cells, as well as CD4+ Tregs that also expressed CD45RC (Käser T, 2008a), 
CD8ǂ, and MHC-II (Käser T, 2008b). Our understanding the mechanism of porcine Treg 
suppression is still in its infancy. A recent publication by Käser et al demonstrated that Treg 
suppression can occur in any one of three ways: 1) cell-contact dependent, 2) production of 
IL-10 or TGF-ǃ, or 3) by competing for IL-2 (Käser T, 2011). Interestingly, the authors 
showed that IL-10 was produced by CD4+CD25dim cells, which have lower suppressive 
activity in swine (Käser T, 2008a). This suggests that IL-10 is likely produced by activated 
Th2 cells rather than regulatory T cells. 
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7. Regulatory T cells and pig viral diseases 
7.1 The immune response to porcine reproductive and respiratory syndrome virus 
Since the initial description of porcine reproductive and respiratory syndrome (PRRS) in the 
USA in 1987 (Collins JE, 1992; Keffaber, 1989), the disease has been shown to be endemic in 
many swine producing countries, and is now considered to be the most important disease of 
swine worldwide (www.prrs.org,(Xiao Z, 2004)). In the USA alone, economic losses caused 
by PRRS virus (PRRSV) infection are estimated to total $560 million (www.prrs.org). PRRSV 
is a single-stranded, positive sense RNA virus in the Arteriviridae family, order Nidovirales 
(Cavanaugh, 1997). Other Arteriviridae include lactate dehydrogenase-elevating virus, 
equine arteritis virus, and simian hemorrhagic fever virus (Cavanaugh, 1997). Within a 
susceptible herd, reproductive failure due to PRRSV infection can range from sporadic 
abortions to abortion storms that may persist within the herd for up to 6 months (Rossow, 
1998). Third-trimester exposure may manifest as late-term abortion, or stillborn, partially 
autolyzed, or mummified fetuses (Rossow, 1998). Neonatal infection results in severe 
dyspnea and tachypnea, and mortality of up to 100%, while disease in weaned pigs is 
primarily due to pneumonia and secondary bacterial or viral infections (Rossow, 1998). In 
addition to clinical disease, PRRSV infection is associated with decreased local cellular 
immunity, resulting in increased susceptibility to secondary bacterial and viral infections, 
including Streptococcus suis, Haemophilus parasuis, Mycoplasma hyopneumoniae, Salmonella 
choleraesuis, and swine influenza virus (Riber U, 2004; Rossow KD, 1995; Zeman D, 1993). 
Piglets infected with PRRS in utero have a decreased innate immune response to bacterial 
pathogens (Riber U, 2004). Riber and colleagues showed that in utero infection with PRRSV 
inhibits the phagocytic ability of blood macrophages against Salmonella spp., and inhibits the 
oxidative burst capacity of alveolar macrophages (Riber U, 2004). Additionally, both PRRSV 
infection and vaccination decreases the efficiency of vaccines against Mycoplasma 
hyopneumoniae (Thacker EL, 2000) and porcine pestivirus (Suradhat S, 2006). Infection and 
vaccination with PRRSV induces a rapid, non-neutralizing antibody response, and an early, 
weak gamma interferon (IFN-) response (Meier WA, 2003; Wesley RD, 2006). The initial 
IFN- response is not PRRSV-specific and may be a result of activation of natural killer cells 
(Wesley RD, 2006). A PRRSV-specific T lymphocyte IFN- response does not appear until at 
least 2 weeks after infection (Xiao Z, 2004). The IFN- response gradually increases and 
plateaus at 6 months postinfection, and is associated with a slow increase in neutralizing 
antibody (Lopez OJ, 2004; Meier WA, 2003). Protective immunity is associated with both an 
IFN- and neutralizing antibody response; however, peak viremia and shedding occur 
before development of neutralizing antibody and IFN- (Lopez OJ, 2004). Acute infection is 
characterized by high viral load in alveolar and tissue macrophages, and may last up to one 
month. The acute infection is followed by persistence of lower levels of virus in lymphoid 
tissue and then clearance after several months (Lopez OJ, 2004). The cause of the delayed 
IFN- and neutralizing antibody response resulting in persistent infection is unknown. 
Meier et al. were unable to enhance the induction of PRRSV-specific IFN- secreting cells 
and generation of neutralizing antibody using an adjuvant that enhances the immune 
response to pseudorabies modified live vaccine (Meier WA, 2003). These data suggest that 
the virus somehow modulates the immune response to not only delay the response to the 
virus itself, but to also decrease the ability to mount a protective response against secondary 
infection. The ability to induce a rapid IFN-Ǆ response is not only important for viral 
clearance, but also heterologous protection by vaccination (Díaz I, 2006; Martelli P, 2009). 
www.intechopen.com
Inflammation, Chronic Diseases and Cancer –  
Cell and Molecular Biology, Immunology and Clinical Bases 
 
132 
Current vaccine strains do not provide adequate heterologous protection because of their 
inability to stimulate an adequate IFN-Ǆ response. One reason for the inadequate IFN-Ǆ may 
be due to the ability of PRRSV to stimulate regulatory T cells in vitro (Silva-Campa E, 2009). 
The mechanism of immune modulation by PRRSV is unknown. PRRSV infection results in a 
significant upregulation of IL-10 expression in peripheral blood mononuclear cells and 
pulmonary alveolar macrophages in vivo and in vitro, and the upregulation of IL-10 is 
increased significantly with concurrent M. hyopneumoniae infection (Suradhat S, 2003; 
Thanawongnuwech R, 2004). The increase in IL-10 expression correlates with an increased 
percentage of lymphocytes in bronchoalveolar lavage cells, suggesting that the lymphocytes 
are involved in cytokine production in the lungs (Suradhat S, 2003). 
7.1.1 Immune modulation mediated by interleukin-10 
Low levels of interleukin-10 (IL-10) stimulate the proliferation of B cells, and activate natural 
killer (NK) cells and CD8+ cytotoxic T cells (Vicari AP, 2004). However, the primary action 
of IL-10 is to inhibit inflammatory cytokines and antagonize the function of antigen 
presenting cells, including immature dendritic cells (DC) (Enk, 2005). In humans and mice, 
exposure of immature DCs to IL-10 in vitro results in decreased surface expression of MHC 
class I and II molecules, reduction of costimulatory molecules, and inhibition of pro-
inflammatory cytokines including IL-1, IL-6, TNF, and IL-12 (Enk, 2005). Additionally, IL-
10 inhibits the synthesis of pro-inflammatory cytokines, the production of nitric oxide, and 
MHC class II expression by macrophages (Fiorentino DF, 1991; Gazzinelli RT, 1992). Since 
IL-12-mediated production of IFN- by pulmonary alveolar macrophages reduces PRRS 
viral titers in the lungs and serum (Carter QL, 2005), inhibition of IL-12 synthesis by IL-10 
likely enhances the occurrence of natural disease. IL-10 affects innate immunity by 
inhibiting the response to Toll-like receptors (TLR), including TLR7 and TLR8 that recognize 
single-stranded viral RNA (Vicari AP, 2004). IL-10 - treated DCs also induce the 
proliferation of regulatory T cells (Tregs) as well as antigen-specific anergy in CD4+ and 
CD8+ T lymphocytes (Enk, 2005). Importantly, IL-10 not only plays a role in the 
development of type 1 Tregs (Tr1), but is also one of the primary mechanisms by which Tregs 
inhibit effector T lymphocyte function (Vicari AP, 2004). In previous experiments, we have 
shown that PRRSV infection increases the number of CD4+CD25+FoxP3+ regulatory T cells 
in the lungs and PBMC of pigs (LeRoith, unpublished). Others have shown that the induced 
Tregs produce TGF-ǃ, consistent with a Th3 phenotype,(Silva-Campa E, 2009) indicating that 
the cells are not only increased, but are also functional. Since intracellular viral ssRNA is 
recognized by TLR7 and 8, and TLR7- and 8-signalling downregulates Tregs (Dai J, 2009), it is 
unlikely that this increase in Treg numbers is merely a result of infection.  
Which components of the virus are responsible for Treg proliferation are unknown, but are 
currently under investigation by our group. Importantly, we were able to demonstrate that 
Treg induction by PRRSV results in increased susceptibility to natural Mycoplasma 
hyopneumoniae infection (LeRoith T, 2011). In this study, pigs were inoculated with a virulent 
strain of PRRSV and a modified live vaccine that was derived from the same strain. In 
attenuation of this virus to produce the vaccine strain, approximately 30% of the mutations 
were in the replicase region (ORF 1)(Yuan S, 2001) and the majority of the mutations in this 
region were silent. Another 35% of the mutations were in the structural proteins, and the 
majority of mutations resulted in conservative or non-conservative amino acid 
changes(Yuan S, 2001). We hypothesized that even with changes in the non-structural and 
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structural proteins that decrease the pathogenicity, the mutations did not alter the virus’s 
ability to stimulate Tregs. Consistent with our hypothesis, we found that, although 
attenuated, the vaccine strain did not differ from the parent strain in its ability to activate 
Tregs. Although the animals were protected against PRRS challenge, animals in the 
attenuated vaccine group did not differ from animals in the virulent group in the severity of 
M. hyopneumonia-mediated disease (Table 2) (LeRoith T, 2011). Similar to previous findings 
that infection with wild type PRRSV or vaccination with PRRS MLV vaccines has been 
shown to decrease the efficacy of M. hyopneumoniae vaccines (Thacker EL, 2000), inoculation 
with all three PRRSV in this study resulted in activation regulatory T cells and likely 
decreased the ability of the pigs to mount an effective anti-bacterial immune.  
 
 
Fig. 3. Modified live virus vaccine and PRRSV infection significantly increases regulatory T 
cells 10 days post infection. The graph represents mean differences in regulatory T cells as 
determined by flow cytometry. Error bars represent standard errors. *= significantly 
different from the control (p < 0.05). PRV, pseudorabies virus; MLV, modified live virus 
vaccine; VR-2332, reference strain of porcine reproductive and respiratory syndrome virus; 
VR-2385, pathogenic strain of porcine reproductive and respiratory syndrome virus. 
(modified from (LeRoith T, 2011)) 
Importantly, vaccine efficacy appears to be related to the ability to stimulate IFN-Ǆ 
production. Also, efficacy against heterologous virus challenge seems to correlate more with 
the ability to stimulate IFN-Ǆ than homology of the vaccine strain to the infective strain. 
Current vaccines fail to protect against other strains (Mateu E, 2007), which may be due to 
their inability to stimulate IFN-Ǆ production. Our study was the first to show the correlation 
between vaccine induction of Tregs and increased susceptibility to bacterial infection. 
Although Tregs that are induced by PRRS in vitro produce TGF-ǃ (Silva-Campa E, 2009), the 
induction of Tregs may indirectly result in IL-10 production, a phenomenon that is well 
established in the PRRS literature (Feng WH, 2003; Suradhat S, 2003). Production of IL-10 
instead of IFN-Ǆ by the MLV vaccine strain would lead to a lack of heterologous protection, 
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and decreased efficacy of other vaccines, as seen by other authors (Thacker EL, 2000). Our 
results suggest that mutations in the vaccine strain that result in attenuation of the virus do 
not alter the virus’s ability to stimulate Tregs (LeRoith T, 2011). This information can help us 
design vaccines in which the Treg-stimulating epitopes can be mutated or deleted in order to 
stimulate a robust virus-specific IFN- response, and provide protection against 
heterologous strains (LeRoith T, 2011).  
 
Treatment Group Number of pigs with lung lesions        Lung lesion scores 
Control 3/5 
 
2.2 + 0.96 
PRV vaccine 5/7 2.67 + 0.78 
PRRSV MLV vaccine 7/8 3.14 + 0.78** 
PRRSV VR-2332 8/8 3.75 + 1.06* 
PRRSV VR-2385 5/8 3 + 1.2 
* Significantly different from the control (p = 0.024) 
**Trend towards a significant difference from the control (p = 0.086) 
Table 2. Incidence and severity of Mycoplasma hyopneumoniae microscopic lung lesions 
((LeRoith T, 2011)) 
7.2 Small single-stranded circular DNA viruses 
Porcine circovirus 2 (PCV2) is a small, single stranded, non-enveloped, circular DNA virus 
in the family Circoviridae. PCV2-associated diseases are of the most economically important 
diseases in swine, and include post-weaning multisystemic wasting syndrome (PMWS) and 
porcine dermatitis and nephropathy syndrome (PDNS) (Allan GM, 2000). Porcine 
circoviruses are widespread in the United States pork industry, and can often be isolated 
from both pork products and human feces (Li L, 2009). The contamination of human 
rotavirus vaccines by porcine circovirus type 1 and type 2 led to the temporarily suspension 
of the licensed rotavirus vaccines [http://www.virology.ws/2010/03/22/porcine-
circovirus-dna-in-rotavirus-vaccine/]. Although PCV2 has been recognized as necessary to 
produce PCVAD, it is difficult to experimentally reproduce the disease with PCV2 alone 
(Magar R, 2000),(Allan GM, 2003). Typically infection by other viruses, immune 
stimulation, or vaccination is required to reproduce clinical disease (Krakowka S, 2001). 
Other small, single stranded, circular DNA viruses infecting both humans and other 
animals are of the genus Anellovirus, including Torque teno virus (TTV) and TTV-like 
mini virus (TLMV) (Biagini, 2004). TTV is ubiquitous in the human population; however 
no specific disease has been linked to TTV infection. Interestingly, TTVs are more 
frequently reported in malignant biopsies from human compared to controls (zur Hausen 
H, 2009) and are associated, at least epidemiologically with liver disease, respiratory 
disease, cancer, and blood disorders (Okamoto, 2009). Additionally, higher TTV viral 
loads are found in patients with systemic lupus erythematosis (SLE) and idiopathic 
inflammatory myopathies (Gergely P Jr, 2006). Swine TTV in conjunction with a 
respiratory virus has also been shown to produce PDNS without PCV2 in gnotobiotic pigs 
(Krakowka S, 2008), producing lesions not seen with the respiratory virus alone. How 
TTV and other circoviruses contribute to disease is unknown, but there is evidence that 
anelloviruses affect both innate and adaptive immunity and can impact how the infected 
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host can respond to other pathogens (Maggi F, 2009). Some authors suggest that the role 
of TTV in carcinogenesis may be due to its effect on antitumoral immunity (zur Hausen 
H, 2009). Other small, single-stranded DNA viruses include human bocavirus, human 
parvovirus 4, and parvovirus B19 (B19). B19, the causative agent of Fifth disease in 
children, typically causes self-limiting disease in immunocompetent individuals; 
however, virus has been shown to persist in the bone marrow several years after primary 
infection (Servant-Delmas A, 2010). The mechanism of persistence is unknown. PCV2 is 
ubiquitous in the swine industry, and genetically similar strains have been isolated from 
both diseased and healthy pigs. There is overwhelming evidence that PCV2 has an 
immunomodulatory effect by infecting macrophages and dendritic cells (DC’s) and 
inducing DC maturation (Vincent IE, 2005). Pigs with PMWS have higher viral loads of 
PCV2 (Rosell C, 1999),(Rovira A, 2002),(Liu Q, 2000), suggesting that disease is associated 
with enhanced PCV2 replication. One of the major contributors to the development of 
PMWS is co-infection with porcine reproductive and respiratory syndrome virus 
(PRRSV). Pigs with PMWS have an increase in monocytes, the presence of low-density 
immature granulocytes in peripheral blood; and a decrease in CD4+ and CD4+CD8+ T 
lymphocytes and B lymphocytes (Darwich L, 2002), (Segalés J AF, 2001). Pigs co-infected 
with PCV2 and PRRSV have more severe lymphoid depletion and enhanced PCV2 
replication and tissue distribution (Allan GM, 2000; Harms PA SS, 2001; Rovira A, 2002), 
suggesting that the interaction between the two viruses is important in the pathogenesis 
of clinical disease. The effect of the interaction between the two viruses on the immune 
system is not well understood. It has been suggested that immune stimulation by PRRSV 
enhances PCV2-mediated disease (Krakowka S, 2001). However; PRRSV, both infection 
and vaccination, has been shown to non-specifically dampen the immune response to 
other infectious agents (Suradhat S, 2003; Thacker EL, 2000). Additionally, a protective 
effect of porcine parvovirus and erysipelas vaccination against PMWS was shown in 
piglets born to PCV2 infected sows, further supporting the idea that factors other than 
immune stimulation may be involved in clinical disease. Importantly, when PMWS is 
produced by a combination of PCV2 and PRRSV, although current vaccines against PCV2 
are able to decrease the severity of PMWS-associated lesions, the vaccines alone are 
ineffective at completely diminishing the lesions to those of PRRSV infection alone 
(Opriessnig T MD, 2008). The contribution of the immune effects of each virus in 
producing clinical PMWS is unknown. PRRSV infects and replicates in alveolar 
macrophages and dendritic cells, resulting in IL-10 production and proliferation of 
regulatory T cells. PCV2 is taken up by DCs and alveolar macrophages but does not 
replicate in these cells and has no effect on them other than to increase differentiation of 
DCs. Importantly, generally co-infection by both viruses is needed to produce PMWS. 
Presumably, PCV2 may enhance differentiation of DCs, thereby increasing the number of 
cells available for PRRSV infection, resulting in increased IL-10 production, and 
regulatory T cell activation. Since Treg activation is associated with a decreased IFN- 
response, and IFN- is necessary for protective immunity against PCV2, PRRSV-mediated 
activation of regulatory T cells may then dampen the immune response to PCV2, resulting 
in increased virus replication and clinical disease. We are interested in determining if the 
effects of PCV2 on DC maturation and PRRSV-mediated activation of Tregs is enhanced in 
pigs with endemic PCV2 infection, or if PCV2 infection at the time of PRRSV infection is 
necessary for developing PMWS. Our data shows that PCV2 is able to induce regulatory T 
cells (Tregs) in vitro (Fig 4), and this effect is enhanced by the addition of a second virus, 
PRRSV (Cecere T, manuscript under review). 
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Fig. 4. PCV2 and PCV2/PRRSV co-infection of porcine dendritic cells results inactivation of 
CD25+FoxP3+ T lymphocytes in vitro compared to the control (p < 0.05).  
What is unknown is whether or not chronic or persistent PCV2 or acute infection is 
associated with more severe pulmonary immunosuppression (as defined by Treg activation 
and suppression of effector T cell function, IL-10 production, and suppression of IFN-Ǆ 
production), leading to more severe manifestation of PMWS. It is also not yet clear if pigs 
persistently infected with PCV2 are at a higher risk of developing PMWS when infected 
with PRRSV than pigs acutely infected with PCV2 and PRRSV. Additionally, it is not known 
if acute PCV2 infection in pigs already persistenly infected with a different PCV2 genotype 
is associated with a higher incidence of PMWS when infected with PRRSV. 
8. Conclusion 
Regulatory T cells are critical for maintaining immune tolerance and immune homeostasis 
by protecting against devastating autoimmune disease and overwhelming inflammation. 
Without these subsets of T cells, animals quickly succumb to inflammatory or autoimmune 
diseases. The dual role of Tregs fits well into the perspectives proposed by Khatami that 
unresolved inflammation is the loss of balance between the “Yin” or tumoricidal and 
“Yang” or tumorigenic arms of acute inflammation (Khatami, 2008, 2009, 2011). Tregs play a 
vital role in preventing what Khatami terms “pathogen-induced immunological chaos,” the 
“immune tsunami,” or cytokine storm can then lead to inflammatory disease and cancer 
(Khatami, 2011). Immunologists are currently trying to identify strategies to enhance 
regulatory T cell activation to protect against inflammatory disease such as systemic lupus 
erythematosis and rheumatoid arthritis. However, some viruses, including PRRSV in pigs, 
have exploited these cells to enhance their survival and replication in the host. Activation of 
regulatory T cells by viruses dampens the immune response to the virus and allows them to 
replicate and persist in host tissues. Understanding the mechanism of Treg activation by 
viruses is critical for identifying new strategies to prevent the effects on the host. In many 
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cases, activation of Tregs not only dampens the immune response to the virus, but non-
specifically dampens the immune response to other pathogens. While the initial immune 
suppression likely plays a role in virus persistence, the non-specific immune suppression is 
one of the mechanisms by which secondary infection can occur. The complete effects of 
these viruses on the immune response of the host are still under investigation. The ability of 
certain viruses to stimulate regulatory provides valuable insight as to how viruses modulate 
the immune system. Understanding the mechanisms of Treg induction is important in 
determining the contribution of RNA and small single-stranded circular DNA virus like 
PCV2, TTV, and parvovirus to the development of disease. Understanding the contribution 
of the immune response to viruses is also essential for vaccine development. PRRSV and 
PCV2 infection in swine provide a valuable animal model to study the immune effects of 
viruses because pigs are outbred and are immunologically similar to humans. Additionally, 
germ-free and colostrum deprived pigs are relatively easy to derive and function well in the 
experimental environment. With these models, we may be able to uncover some of the 
mysteries of the contribution of Tregs in chronic infectious and inflammatory disease. 
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